Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health & Wellness Today New York.
Press releases published on July 24, 2025
POP BIO and CEPI announce collaboration for faster responses to Disease X
EIN Presswire
·
July 24, 2025
POP BIO announces an award of up to $1.5M award from CEPI to advance the SNAP platform into the development of a SFTS vaccine BUFFALO, NY, UNITED STATES, July 24, 2025 /EINPresswire.com/ -- New research is set to investigate a pioneering approach using …
PTSD Awareness Campaign Launches to Honor Late Veteran and Fire Captain Through National Speaking Initiative
EIN Presswire
·
July 24, 2025
Fighting The Flames Enterprises leads effort to raise awareness of PTSD’s impact on veterans and first responders across the U.S. NY, UNITED STATES, July 24, 2025 /EINPresswire.com/ -- A nationwide mental health awareness initiative focusing on post- …
New York Skyline Shines Bright for Sarcoma Awareness on July 25
EIN Presswire
·
July 24, 2025
New York City landmarks will light up yellow on July 25 to raise awareness for sarcoma and show support for patients, survivors, and families. NEW YORK CITY, NY, UNITED STATES, July 24, 2025 /EINPresswire.com/ -- On July 25, 2025, landmarks across the …
Southampton Hospital Foundation Presents the 67th Summer Party: A Night in Marrakesh
EIN Presswire
·
July 24, 2025
The evening will celebrate honorees Kate …
NYF Health Opens 2025 Awards with Industry Leaders Allison Ceraso and Kathleen Nanda at the Helm of Executive Juries
EIN Presswire
·
July 24, 2025
NYF Health Expands with Bold New Categories and the 2025 CFE Campaign from The Bloc NEW YORK, NY, UNITED STATES, July 24, 2025 /EINPresswire.com/ -- The 2025 New York Festivals Health Awards, honoring excellence in Healthcare, Wellness and …
This August 18: Never Give Up Day — The Celebration Behind Every Cause
EIN Presswire
·
July 24, 2025
Because every cause, every movement, and every mission begins with someone who refused to give up. NEW YORK, NY, UNITED STATES, July 24, 2025 /EINPresswire.com/ -- In a world shaped by purpose-driven work, urgent causes, and bold changemakers, Never …
Aja Health and Wellness Inc. Provides Update on Delay in Filing Financial Statements
GlobeNewswire
·
July 24, 2025
Not for dissemination in the United States of America VANCOUVER, British Columbia, July 24, 2025 (GLOBE NEWSWIRE) -- Aja Health and Wellness Inc. ("Aja" or the "Company") (TSXV:Aja) announces that it is getting closer to filing its annual audited financial …
PROCEPT BioRobotics® President and CEO Dr. Reza Zadno to Retire, Company Appoints Larry L. Wood as New President and CEO
GlobeNewswire
·
July 24, 2025
Larry L. Wood to join PROCEPT BioRobotics effective September 2, 2025 Company confirms strong underlying business trends and pre-announces 2Q25 revenue of approximately $79.2 million, representing annual growth of 48% SAN JOSE, Calif., July 24, 2025 (GLOBE …
Scienture Holdings, Inc. Obtains $1.2 Million in Bridge Funding
GlobeNewswire
·
July 24, 2025
Commack, NY, July 24, 2025 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX) (the “Company”) a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to patients, physicians and caregivers …
Algernon Announces Closing of the Private Placement Financing
GlobeNewswire
·
July 24, 2025
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, July 24, 2025 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), …
Rakovina Therapeutics Announces Warrant Exercise Incentive Program
GlobeNewswire
·
July 24, 2025
VANCOUVER, British Columbia, July 24, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSXV: RKV) (the “Company” or “Rakovina”) a biopharmaceutical company advancing cancer therapies through artificial intelligence (AI)-powered drug discovery is …
Profound Medical to Release Second Quarter 2025 Financial Results on August 14 – Conference Call to Follow
GlobeNewswire
·
July 24, 2025
TORONTO, July 24, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased …
ReShape Lifesciences® Announces Partial Adjournment of Special Meeting of Stockholders
GlobeNewswire
·
July 24, 2025
Partial Adjournment for Proposal 2, Asset Sale Proposal, and Proposal 3, Charter Amendment Proposal; All Other Proposals Required for Merger Were Approved Stockholders are encouraged to vote FOR Proposals 2 and 3 by Calling 1-877-750-8310 (from the U.S. …
CooperCompanies Announces Release Date for Third Quarter 2025
GlobeNewswire
·
July 24, 2025
SAN RAMON, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading medical device company, announced today it will report third quarter 2025 financial results on Wednesday, August 27, 2025, at 4:15 PM ET. Following the release, …
HeartSciences Provides Business Update and Reports Fiscal 2025 Financial Results
GlobeNewswire
·
July 24, 2025
Southlake, TX, July 24, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (“AI”)-powered medical technology company transforming ECGs/EKGs to enable earlier detection of heart …
The Ensign Group Reports Second Quarter 2025 Results; Raises Annual Earnings and Revenue Guidance
GlobeNewswire
·
July 24, 2025
SAN JUAN CAPISTRANO, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign(TM) group of companies, which provide post-acute healthcare services and invest in the long-term healthcare industry, …
Pharvaris Announces Closing of $201.2 Million Upsized Public Offering of Ordinary Shares and Pre-Funded Warrants and Full Exercise of Underwriters’ Option to Purchase Additional Shares
GlobeNewswire
·
July 24, 2025
ZUG, Switzerland, July 24, 2025 (GLOBE NEWSWIRE) -- Pharvaris N.V. (“Pharvaris,” Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to address unmet needs of those living with bradykinin-mediated …
Preclinical Data Demonstrate Anti-Siglec-15 Treatment Improves Bone Microarchitecture and Reduces Fracture Incidence in Mice with Moderate-to-Severe Osteogenesis Imperfecta
GlobeNewswire
·
July 24, 2025
BELTSVILLE, Md., July 24, 2025 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class and best-in-class therapies to treat cancer, today announced the …
Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2025 Financial Results on August 7, 2025
GlobeNewswire
·
July 24, 2025
CLEARWATER, Fla., July 24, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ: APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion® and the AYON Body …
Iovance Biotherapeutics to Host Second Quarter and First Half 2025 Financial Results and Corporate Updates Webcast on Thursday, August 7, 2025
GlobeNewswire
·
July 24, 2025
SAN CARLOS, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with …